The Srb1+1050T allele is associated with metabolic syndrome in children but not with cholesteryl ester plasma concentrations of high-density lipoprotein subclasses

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 2, 2012, Pages 110-116

  Juárez Meavepeña, Minerva ^a   Carreón Torres, Elizabeth ^a   López Osorio, Cristhel ^a   García Sánchez, Cynthia ^a   Gamboa, Ricardo ^a   Torres Tamayo, Margarita ^b   Fragoso, José Manuel ^a   Rodríguez Pérez, José Manuel ^a   Vargas Alarcón, Gilberto ^a   Pérez Méndez, Oscar ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; POLYACRYLAMIDE GEL; TRIACYLGLYCEROL;

ADOLESCENT; ALLELE; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STAINING; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; AGE OF ONSET; ALLELES; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL ESTERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPOPROTEINS, HDL; MALE; METABOLIC SYNDROME X; OSMOLAR CONCENTRATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SCAVENGER RECEPTORS, CLASS B;

EID: 84858809829     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2011.0071     Document Type: Article

References (45)

1. Assmann G, Schulte H, von Eckardstein A, et al. Highdensity lipoprotein cholesterol as a predictor of coronary heart disease risk: The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996;124:S11-S20.
2. Navab M, Reddy ST, Van Lenten BJ, et al. HDL and cardiovascular disease: Atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 2011;8:222-232.
3. Rye KA, Bursill CA, Lambert G, et al. The metabolism and anti-atherogenic properties of HDL. J Lipid Res 2009;50:S195-S200.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
5. Grundy SM, Cleeman JI, Daniels SR, et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation, 2005;112: 1-18.
6. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-A new worldwide definition. Lancet 2005;366:1059-1062.
7. Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004;291:2847-2850.
8. de Ferranti SD, Gauvreau K, Ludwig DS, et al. Inflammation and changes in metabolic syndrome abnormalities in US adolescents: Findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys. Clin Chem 2006;52:1325-1330.
9. Miranda PJ, DeFronzo RA, Califf RM, et al. Metabolic syndrome: Definition, pathophysiology, and mechanisms. Am Heart J 2005;149:33-45.
10. Nguyen QM, Srinivasan SR, Xu JH, et al. Changes in risk variables of metabolic syndrome since childhood in pre-diabetic and type 2 diabetic subjects: The Bogalusa Heart Study. Diabetes Care 2008;31:2044-2049.
11. Srinivasan SR, Meyers L, Berenson GS. Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects: The Bogalusa Heart Study. Hypertension 2006;48:33-49.
12. Festa A, Williams K, Hanley AJ, et al. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation 2005;111:3465-3472.
13. Williams PT, Krauss RM, Nichols AV, et al. Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis. J Lipid Res 1990;31:1131-1139.
14. Florentin M, Liberopoulos EN, Wierzbicki AS, et al. Multiple actions of high-density lipoprotein. Curr Opin Cardiol 2008; 23:370-378.
15. Kimura T, Tomura H, Sato K, et al. Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells. J Biol Chem 2010;285:4387-4397.
16. Escolà-Gil JC, Rotllan N, Julve J, et al. In vivo macrophagespecific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection. Atherosclerosis 2009;206:321-327.
17. Pérez-Méndez O, Torres-Tamayo M, Posadas-Romero C, et al. Abnormal HDL subclasses distribution in overweight children with insulin resistance or type 2 diabetes mellitus. Clin Chim Acta 2007;376:17-22.
18. Magkos F, Mohammed BS, Mittendorfer B. Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women. Int J Obes 2008;32: 1655-1664.
19. Morgan J, Carey C, Lincoff A, Capuzzi D. High-density lipoprotein subfractions and risk of coronary artery disease. Curr Atheroscler Rep 2004;6:359-365.
20. García-Sánchez C, Torres-Tamayo M, Juárez-Meavepena M, et al. Lipid plasma concentrations of HDL subclasses determined by enzymatic staining on polyacrylamide electrophoresis gels in children with metabolic syndrome. Clin Chim Acta 2011;412:292-298.
21. Acton S, Rigotti A, Landschulz KT, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996;271:518-520.
22. Wang N, Weng W, Breslow JL, et al. Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores: In vivo evidence that SR-BI is a functional high density lipoprotein receptor under feedback control. J Biol Chem 1996;271:21001-21004.
23. Silver DL, Jiang XC, Arai T, et al. Receptors and lipid transfer proteins in HDL metabolism. Ann NY Acad Sci 2000;902:103-111.
24. Webb NR, Cai L, Ziemba KS, et al. The fate of HDL particles in vivo after SR-BI-mediated selective lipid uptake. J Lipid Res 2002;43:1890-1898.
25. Toledo-Ibelles P, García-Sánchez C, Avila-Vazzini N, et al. Enzymatic assessment of cholesterol on electrophoresis gels for estimating HDL size distribution and plasma concentrations of HDL subclases. J Lipid Res 2010;51:1610-1617.
26. Zimmet P, Alberti KG, Kaufman F, et al. IDF Consensus Group. Themetabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes 2007;8:299-306.
27. www.cdc.gov/nccdphp/dnpa/bmi/childrens-BMI/about-childrens-BMI.htm/.
28. DeLong DM, DeLong ER, Wood PD, et al. A comparison of methods for the estimation of plasma low-and very lowdensity lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA 1986;256:2372-2377.
29. Carreón-Torres E, Juárez-Meavepen a M, Cardoso-Saldan a G, et al. Pioglitazone increases the fractional catabolic and production rates of high-density lipoproteins apo AI in the New Zealand White Rabbit. Atherosclerosis 2005;181: 233-240.
30. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
31. Blanche PJ, Gong EL, Forte TM, et al. Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta 1981;665:408-419.
32. Huesca-Gomez C, Carreón-Torres E, Nepomuceno-Mejía T, et al. Contribution of cholesteryl ester transfer protein and lecithin:cholesterol acyltranferase to HDL size distribution. Endocr Res 2004;30:403-415.
33. Warnick GR, McNamara JR, Boggess C, et al. Polyacrylamide gradient gel electrophoresis of lipoprotein subclasses. Clin Lab Med 2006;26:803-846.
34. Lahiri DK, Nurnberger Jr JI. A rapid non-enzymatic method for the preparation HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991;19:5444.
35. Cao G, Garcia CK, Wyne KL, et al. Structure and localization of the human gene encoding SR-BI/CLA-1. Evidence for transcriptional control by steroidogenic factor 1. J Biol Chem 1997;272:33068-33076.
36. Mahtani MM, Widén E, Lehto M, et al. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet 1996;14:90-94.
37. Bektas A, Suprenant ME, Wogan LT, et al. Evidence of a novel type 2 diabetes locus 50cM centromeric to NIDDM2 on chromosome 12q. Diabetes 1996;48:2246-2251.
38. Lindgren CM, Mahtani MM, Widén E, et al. Genomewide search for type 2 diabetes mellitus susceptibility loci in Finnish families: The Botnia study. Am J Hum Genet 2002;70: 509-516.
39. Osgood D, Corella D, Demissie S, et al. Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: The Framingham study. J Clin Endocrinol Metab 2003;88:2869-2879.
40. Durst R, Colombo R, Shpitzen S, et al. Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: Positive selection is not always necessary to account for disease incidence among Ashkenazi Jews. Am J Hum Genet 2001;68:1172-1188.
41. Plat J, Mensink RP. Relationship of genetic variation in genes encoding apolipoprotein A-IV, scavenger receptor BI, HMGCoA reductase, CETP and apolipoprotein E with cholesterol metabolism and the response to plant stanol ester consumption. Eur J Clin Invest 2002;32:242-250.
42. Constantineau J, Greason E, West M, et al. A synonymous variant in scavenger receptor, class B, type I gene is associated with lower SR-BI protein expression and function. Atherosclerosis 2010;210:177-182.
43. Brunham LR, Tietjen I, Bochem AE, et al. Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans. Clin Genet 2011;79:575-581.
44. Vergeer M, Korporaal SJ, Franssen R, et al. Genetic variant of the scavenger receptor BI in humans. N Engl J Med 2011; 364:136-145.
45. Naj AC, West M, Rich SS, et al. Association of scavenger receptor class B type I polymorphisms with subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Genet 2010;3:47-52.